|
Authors
|
Sample size
|
Treatment duration
| |
Symptom recurrence rates
|
Comparator recurrence rate
|
|---|
| | | |
9 months
|
12 months
|
18 months
|
24 months
|
36 months
| |
|---|
|
Kane J et al. [24].
|
28
|
Not specified
| |
41%
| | | |
0%
|
|
Crow T et al. [26].
|
120
|
Not specified
| | | |
62%
| |
46%
|
|
Gitlin M et al. [21].
|
53
|
3 months in remission
| |
78%
| |
96%
| |
-
|
|
Wunderink L et al. [25].
|
161
|
6 months in remission
| | |
43%
| | |
21%
|
|
Chen E. et al. [22].
|
178
|
12 months +
| |
79%
| | | |
41%
|
|
Gaebel W. et al. [27].
|
44
|
12 months
| |
57%
| | | |
4%
|
|
Boonstra G. et al. [23].
|
20
|
12 months min remission
|
82%
| | | | |
12%
|
|
Emsley R et al. [10].
|
33
|
24 months
| |
79%
| |
94%
|
97%
|
-
|
